chondroitin-sulfates and Scoliosis

The present study was designed to ascertain how altered biomechanics in adolescent idiopathic scoliotic (AIS) intervertebral discs (IVDs) affected tissue compositions and aggrecan processing compared to age matched and aged human IVDs. Newborn, 2- and 10-year-old ovine IVDs were also examined.. Aggrecan populations were separated by Sepharose CL2B chromatography, composite agarose polyacrylamide gel electrophoresis (CAPAGE) and identified by immunoblotting. The KS and CS content of IVD tissue extracts from AIS IVDs were compared with age-matched normal adolescent IVDs and with old human IVDs. Extracts from newborn, 2- and 10-year-old ovine IVDs were also examined in a similar manner.. Adolescent idiopathic scoliotic IVD Aggrecan populations shared similar levels of polydispersity and aggregatability with hyaluronan as old IVD proteoglycans. CAPAGE demonstrated three aggrecan populations in AIS, aged human and ovine IVDs increased polydispersity and mobility in CAPAGE. AIS IVDs had GAG compositions similar to aged human and ovine IVDs. Sulphated KS (5-D-4) and chondroitin-6-sulphate, 3-B-3(+) were markers of tissue maturation, and chondroitin-4-sulphate, 2-B-6(+) was prominent in immature IVDs but its levels were lower in mature IVDs.. Sulphated KS and 3-B-3(+) CS were prominently associated with IVD maturation and AIS IVDs, while the 2-B-6(+) CS isomer was associated with immature IVD tissues. The polydispersity of aggrecan in AIS IVDs, which was similar to in old human and ovine IVDs, reflected altered processing in the AIS IVDs in response to the biomechanical microenvironments the disc cells were exposed to in AIS IVDs. These slides can be retrieved under Electronic Supplementary Material.

Topics: Adolescent; Aggrecans; Aging; Animals; Child; Child, Preschool; Chondroitin Sulfates; Glycosaminoglycans; Humans; Intervertebral Disc; Proteoglycans; Scoliosis; Sheep; Sheep, Domestic

Clinical and radiological outcomes of lumbar interbody fusion using artificial fusion cages filled with calcium phosphate cements (CPCs) were retrospectively reviewed. Between 2002 and 2011, 25 patients underwent lumbar interbody fusion at Tokushima University Hospital, and 22 patients were enrolled in this study. Of these, 5 patients received autologous local bone grafts and 17 received CPC. Japan Orthopedic Association (JOA) score was used for clinical outcome assessments. Lumbar radiography and computed tomography (CT) were performed at 12, 24 months and last follow-up period to assess bony fusion. The mean JOA score of all patients improved from 9.3 before surgery to 21.0 at 24 months after surgery. Fusion had occurred in 5 of 5 patients in the local bone graft group and in 16 of 17 patients in CPC group at 24 months postoperatively. No surgically related complication was occurred in both groups. CPC is a useful and safe graft material for lumbar interbody fusion.

Topics: Aged; Bone Cements; Bone Transplantation; Chondroitin Sulfates; Female; Follow-Up Studies; Humans; Hydroxyapatites; Image Interpretation, Computer-Assisted; Intervertebral Disc Degeneration; Lumbar Vertebrae; Male; Middle Aged; Osseointegration; Pedicle Screws; Prosthesis Implantation; Retrospective Studies; Scoliosis; Spinal Fusion; Spondylolisthesis; Succinates; Tomography, X-Ray Computed

Tissue-engineering approaches for treating degenerative intervertebral discs aim to regenerate intervertebral disc tissues in order to retard or even reverse the degenerative process. This study was designed to investigate the feasibility of the glutaraldehyde crosslinked gelatin/chondroitin-6-sulfate copolymer scaffold to serve as a bioactive scaffold for culturing human nucleus pulposus (NP) cells in vitro with preservation of the cell viability, cell proliferation, and production of important extracellular matrix, including glycoaminoglycans (GAG) and Type II collagen. Each experimental sample was seeded with 1 x 10(6) human NP cells, and then the cell-scaffold hybrids were cultured in vitro for 6 or 12 weeks. SEM showed a highly porous structure with an average pore size of 100 microm in the copolymer scaffold. Immediately after cell seeding, SEM showed that the seeded cells penetrated deeply and distributed evenly in the copolymer scaffold. Water-soluble tetrazolium salt-1 (WST-1) assay showed good viability and active proliferation of cultured human NP cells in the copolymer scaffolds up to 12 weeks. The cell-scaffold hybrids contained significantly higher levels of sulfated GAG than the control samples (41.29 mug vs 6.04 mug per scaffold). Immunohistochemical study showed Type II collagen fibrils on the surface of scaffold substrate after 6 weeks of cultivation. More abundant deposition of Type II collagen could be detected after 12 weeks. The results achieved in this study indicate that the gelatin/chondroitin-6-sulfate copolymer scaffold is a promising bioactive scaffold for regeneration of nucleus pulposus tissue.

Topics: Biocompatible Materials; Cell Culture Techniques; Cell Proliferation; Cell Survival; Chondroitin Sulfates; Collagen Type II; Coloring Agents; DNA; Extracellular Matrix; Gelatin; Glutaral; Humans; Immunohistochemistry; Intervertebral Disc; Lumbar Vertebrae; Methylene Blue; Microscopy, Electron, Scanning; Polymers; Scoliosis; Tetrazolium Salts; Tissue Engineering